Figure 1. Actuarial Kaplan-Meier survival curves for 270 patients with bone metastases stratified by radiotherapy fractionation (P = 0.0001).
| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website http://www.jocmr.org |
Original Article
Volume 12, Number 2, February 2020, pages 90-99
Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy
Figures
Tables
| Parameters | Favorable score | Intermediate score | Unfavorable score |
|---|---|---|---|
| Median age, years | 67 | 65 | 69 |
| Age ≤ 60 years, % | 22 | 26 | 10 |
| Karnofsky performance status 80 - 100, % | 100 | 49 | 0 |
| Breast cancer, % | 26 | 10 | 0 |
| Renal cell cancer, % | 14 | 8 | 0 |
| Prostate cancer, % | 60 | 29 | 0 |
| Lung cancer, % | 0 | 22 | 47 |
| Colorectal cancer, % | 0 | 5 | 7 |
| Other cancer, % | 0 | 26 | 46 |
| Median point sum | 15 | 12 | 9 |
| Group | 12-month survival | Median survival |
|---|---|---|
| Rades et al favorable | 72% | 24 months |
| Rades et al intermediate | 38% | 8 months |
| Rades et al unfavorable | 9% | 3 months |
| Present study favorable | 71% | 31.8 months |
| Present study intermediate | 30% | 4.4 months |
| Present study unfavorable | 7% | 1.4 months |
| Present study 8 Gy favorable | 43% | 10.0 months |
| Present study 8 Gy intermediate | 13% | 3.0 months |
| Present study 8 Gy unfavorable | 0% | 1.0 month |
| Present study short course favorable | 72% | 31.8 months |
| Present study short course intermediate | 21% | 3.2 months |
| Present study short course unfavorable | 8% | 1.5 months |
| Present study long course favorable | 81% | 54.8 months |
| Present study long course intermediate | 45% | 9.7 months |
| Present study long course unfavorable | 10% | 1.4 months |